# OnCo record paper-berchuck-cfdna-methylation-nepc-detection-ccr-2022 (paper). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/key-papers/paper-berchuck-cfdna-methylation-nepc-detection-ccr-2022/>
  a schema:ScholarlyArticle ;
  onco:kind "paper" ;
  schema:identifier "paper-berchuck-cfdna-methylation-nepc-detection-ccr-2022" ;
  schema:name "Detecting neuroendocrine prostate cancer through tissue-informed cell-free DNA methylation analysis"@en ;
  schema:description "A blood test that reads chemical marks on DNA rather than its letters separated the aggressive neuroendocrine form of prostate cancer from the ordinary form almost perfectly."@en ;
  schema:url <https://onco.cc/key-papers/paper-berchuck-cfdna-methylation-nepc-detection-ccr-2022/> ;
  schema:dateModified "2026-09-25"^^xsd:date ;
  schema:citation <https://doi.org/10.1158/1078-0432.CCR-21-3762>, <https://pubmed.ncbi.nlm.nih.gov/34907080/> ;
  schema:sameAs <https://doi.org/10.1158/1078-0432.CCR-21-3762> ;
  schema:datePublished "2022"^^xsd:gYear ;
  schema:author "Berchuck JE, Baca SC, McClure HM, et al." ;
  onco:cancers <https://onco.cc/cancers/prostate/>, <https://onco.cc/cancers/prostate-mcrpc/>, <https://onco.cc/cancers/prostate-nepc/> ;
  onco:technologies <https://onco.cc/technologies/liquid-biopsy/>, <https://onco.cc/technologies/methylation-profiling/> ;
  onco:targets <https://onco.cc/targets/androgen-receptor/> ;
  onco:pathways <https://onco.cc/pathways/lineage-plasticity-neuroendocrine/>, <https://onco.cc/pathways/epigenetic-reprogramming/> ;
  onco:terms <https://onco.cc/terms/ctdna/>, <https://onco.cc/terms/cfdna/>, <https://onco.cc/terms/histologic-transformation/>, <https://onco.cc/technologies/liquid-biopsy/> ;
  onco:journals <https://onco.cc/journals/clinical-cancer-research/> .